Nasdaq:US$16.44 (+0.08) | HKEX:HK$26.00 (-0.10) | AIM:£2.70 (-0.01)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma